Sensitive and Feasible Specimen Collection and Testing Strategies for Diagnosing Tuberculosis in Young Children.


Journal

JAMA pediatrics
ISSN: 2168-6211
Titre abrégé: JAMA Pediatr
Pays: United States
ID NLM: 101589544

Informations de publication

Date de publication:
01 05 2021
Historique:
pubmed: 23 2 2021
medline: 27 1 2022
entrez: 22 2 2021
Statut: ppublish

Résumé

Criterion-standard specimens for tuberculosis diagnosis in young children, gastric aspirate (GA) and induced sputum, are invasive and rarely collected in resource-limited settings. A far less invasive approach to tuberculosis diagnostic testing in children younger than 5 years as sensitive as current reference standards is important to identify. To characterize the sensitivity of preferably minimally invasive specimen and assay combinations relative to maximum observed yield from all specimens and assays combined. In this prospective cross-sectional diagnostic study, the reference standard was a panel of up to 2 samples of each of 6 specimen types tested for Mycobacterium tuberculosis complex by Xpert MTB/RIF assay and mycobacteria growth indicator tube culture. Multiple different combinations of specimens and tests were evaluated as index tests. A consecutive series of children was recruited from inpatient and outpatient settings in Kisumu County, Kenya, between October 2013 and August 2015. Participants were children younger than 5 years who had symptoms of tuberculosis (unexplained cough, fever, malnutrition) and parenchymal abnormality on chest radiography or who had cervical lymphadenopathy. Children with 1 or more evaluable specimen for 4 or more primary study specimen types were included in the analysis. Data were analyzed from February 2015 to October 2020. Cumulative and incremental diagnostic yield of combinations of specimen types and tests relative to the maximum observed yield. Of the 300 enrolled children, the median (interquartile range) age was 2.0 (1.0-3.6) years, and 151 (50.3%) were female. A total of 294 met criteria for analysis. Of 31 participants with confirmed tuberculosis (maximum observed yield), 24 (sensitivity, 77%; interdecile range, 68%-87%) had positive results on up to 2 GA samples and 20 (sensitivity, 64%; interdecile range, 53%-76%) had positive test results on up to 2 induced sputum samples. The yields of 2 nasopharyngeal aspirate (NPA) samples (23 of 31 [sensitivity, 74%; interdecile range, 64%-84%]), of 1 NPA sample and 1 stool sample (22 of 31 [sensitivity, 71%; interdecile range, 60%-81%]), or of 1 NPA sample and 1 urine sample (21.5 of 31 [sensitivity, 69%; interdecile range, 58%-80%]) were similar to reference-standard specimens. Combining up to 2 each of GA and NPA samples had an average yield of 90% (28 of 31). NPA, in duplicate or in combination with stool or urine specimens, was readily obtainable and had diagnostic yield comparable with reference-standard specimens. This combination could improve tuberculosis diagnosis among children in resource-limited settings. Combining GA and NPA had greater yield than that of the current reference standards and may be useful in certain clinical and research settings.

Identifiants

pubmed: 33616611
pii: 2776607
doi: 10.1001/jamapediatrics.2020.6069
pmc: PMC7900937
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e206069

Subventions

Organisme : NICHD NIH HHS
ID : K23 HD072802
Pays : United States
Organisme : PEPFAR
Pays : United States

Commentaires et corrections

Type : CommentIn

Auteurs

Rinn Song (R)

Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts.
Department of Pediatrics, Harvard Medical School, Boston, Massachusetts.
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.

Eleanor S Click (ES)

US Centers for Disease Control and Prevention, Atlanta, Georgia.

Kimberly D McCarthy (KD)

US Centers for Disease Control and Prevention, Atlanta, Georgia.

Charles M Heilig (CM)

US Centers for Disease Control and Prevention, Atlanta, Georgia.

Walter Mchembere (W)

Kenya Medical Research Institute, Center for Global Health Research, Kisumu, Kenya.

Jonathan P Smith (JP)

Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia.
Northrop Grumman, Atlanta, Georgia.

Mark Fajans (M)

US Centers for Disease Control and Prevention, Atlanta, Georgia.

Susan K Musau (SK)

Kenya Medical Research Institute, Center for Global Health Research, Kisumu, Kenya.

Elisha Okeyo (E)

Kenya Medical Research Institute, Center for Global Health Research, Kisumu, Kenya.

Albert Okumu (A)

Kenya Medical Research Institute, Center for Global Health Research, Kisumu, Kenya.

James Orwa (J)

Kenya Medical Research Institute, Center for Global Health Research, Kisumu, Kenya.

Dickson Gethi (D)

Kenya Medical Research Institute, Center for Global Health Research, Kisumu, Kenya.

Lazarus Odeny (L)

Kenya Medical Research Institute, Center for Global Health Research, Kisumu, Kenya.

Scott H Lee (SH)

US Centers for Disease Control and Prevention, Atlanta, Georgia.

Carlos M Perez-Velez (CM)

Tuberculosis Clinic, Pima County Health Department, Tucson, Arizona.
Infectious Diseases, University of Arizona College of Medicine, Tucson.

Colleen A Wright (CA)

Division of Anatomical Pathology, University of Stellenbosch, Cape Town, South Africa.

Kevin P Cain (KP)

US Centers for Disease Control and Prevention, Kisumu, Kenya.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH